West Pharmaceutical Services, Inc. Common Stock (WST)
221.50
+1.34 (0.61%)
NYSE · Last Trade: Apr 2nd, 7:35 PM EDT
Via Benzinga · March 28, 2025
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at West Pharmaceutical Services (NYSE:WST) and its peers.
Via StockStory · March 25, 2025
Via Benzinga · March 18, 2025
Let’s dig into the relative performance of Fortrea (NASDAQ:FTRE) and its peers as we unravel the now-completed Q4 drug development inputs & services earnings season.
Via StockStory · March 18, 2025

Analyzing WEST PHARMACEUTICAL SERVICES (NYSE:WST)'s Dividend Potential.
Via Chartmill · February 18, 2025
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at drug development inputs & services stocks, starting with UFP Technologies (NASDAQ:UFPT).
Via StockStory · March 13, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Azenta (NASDAQ:AZTA) and its peers.
Via StockStory · March 12, 2025

Via Benzinga · March 7, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Friday. Uncover the top gainers and losers in today's session for valuable insights.
Via Chartmill · February 28, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.
Via Chartmill · February 28, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top S&P500 gainers and losers in today's session.
Via Chartmill · February 24, 2025

Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.
Via Chartmill · February 24, 2025
Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.
Via Talk Markets · February 23, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights.
Via Chartmill · February 21, 2025

Via Benzinga · February 21, 2025

Stay updated with the movements of the S&P500 index in the middle of the day on Tuesday. Discover which stocks are leading as top gainers and losers in today's session.
Via Chartmill · February 18, 2025

Via Benzinga · February 18, 2025

Wall Street rebounds after losing streak; S&P 500 closes 0.07% below record high. Global trade developments influence market direction.
Via Benzinga · February 18, 2025

Eleven large-cap stocks performed poorly in the last week. West Pharmaceutical, The Trade Desk, Fidelity National, and others saw significant declines.
Via Benzinga · February 16, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.
Via Chartmill · February 14, 2025

Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Via Chartmill · February 14, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.
Via Chartmill · February 14, 2025

Via Benzinga · February 14, 2025

Via Benzinga · February 14, 2025

Shares of healthcare products company West Pharmaceutical Services (NYSE:WST)
fell 34.9% in the afternoon session after the company reported disappointing fourth-quarter 2024 results: its full-year revenue and earnings guidance fell short of Wall Street's estimates. Adjusted EPS declined slightly y/y, reflecting margin pressures and a less favorable product mix. These factors contributed to the lower-than-expected full-year EPS guidance.
Via StockStory · February 13, 2025